Get the latest insights

The nature of the relationship between obesity and mental health: an IMI2 SOPHIA qualitative study

One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population

Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis

The role of genetic testing in obesity care: the patient perspective

Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study

Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study

Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study.